StockNews.com Begins Coverage on Curis (NASDAQ:CRIS)
Equities research analysts at StockNews.com assumed coverage on shares of Curis (NASDAQ:CRIS – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $20.00 price target on shares of Curis […]
Equities research analysts at StockNews.com assumed coverage on shares of Curis (NASDAQ:CRIS – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $20.00 price target on shares of Curis […]
